Investigation of focal and non-focal plasticity in patients with schizophrenia. - FöFoLe_838

Forschungsdekanat derLudwig-Maximilians-Universität München0 sites40 target enrollmentJanuary 12, 2016

Overview

No summary available.

Registry

who.int

Start Date

January 12, 2016

End Date

November 30, 2015

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

Forschungsdekanat derLudwig-Maximilians-Universität München

•General inclusion criteria:
•\- Adults 18\-45 yrs.
•\- Ability to understand the study information and to give written informed consent
•Special inclusion criteria:
•\- Patients meeting the ICD\-10 diagnostic criteria of schizophrenia
•\- duration of illness under 2 years in the case of early disease stage
•\- stabel medication for at least one week prior to inclusion in the study in the case of chronically ill patients
•\- in the case of legal supervision by a medical or social care professional written informed consent has to be given by both, the patient and the caregiver/supervisor/lawyer.

•\-Children (\<18 yrs.) or adults \> 45 yrs.
•\-Pregnancy
•\-Participation in an interventional study involving neuroactive medications within the last 6 months.
•\-Neurological disorders: diagnosis of epilepsy, severe brain injury, brain operation or brain implants, Parkinson‘s, increased intracranial pressure, TIA or stroke, subdural haematomas, infarction or haemorrhage, tumour, on\-going acute or chronic infection, cerebral palsy or any other neurological deficit.
•\-Psychiatric disorders: Diagnosis of depression, delusional disorder, anxiety disorder, dementia, organic psychiatric illness or drug dependency (with the exclusion of tobacco dependency).
•\-Other severe medical conditions: Diagnosis of cardiovascular disorder, especially hypotonia or hypertension, pace maker, implanted cardioverter\-defibrillator (ICD) or other implanted devices, respiratory disorders, especially asthma, chronic obstructive pulmonary disease (COPD), severe on\-going , systemic skin disease (neurodermitis, psoriasis) or bone\-structure involving diseases (Pagets, osteoporosis).
•Special exclusion criteria for healthy controls:
•any known psychiatric illness according to ICD\-10 criteria. A screening using the MINI\-Plus interview will be conducted.